Your activity: 2 p.v.

2017 World Health Organization (WHO) classification and grading of pancreatic neuroendocrine neoplasms (PanNENs)

2017 World Health Organization (WHO) classification and grading of pancreatic neuroendocrine neoplasms (PanNENs)
Classification/grade Ki-67 proliferation index* (percent) Mitotic index*
Well-differentiated PanNENs: Pancreatic neuroendocrine tumours (PanNETs)
PanNET G1 <3 <2
PanNET G2 3 to 20 2 to 20
PanNET G3 >20 >20
Poorly differentiated PanNENs: Pancreatic neuroendocrine carcinomas (PanNECs)
PanNEC (G3) >20 >20
Small cell type    
Large cell type    
Mixed neuroendocrine-non-neuroendocrine neoplasm
* The Ki-67 proliferation index is based on the evaluation of ≥500 cells in areas of higher nuclear labelling (so-called hotspots). The mitotic index is based on the evaluation of mitoses in 50 high-power fields (0.2 mm2 each) in areas of higher density, and is expressed as mitoses per 10 high-power fields (2.0 mm2). The final grade is determined based on whichever index (Ki-67 or mitotic) places the tumour in the highest grade category. For assessing Ki-67, casual visual estimation (eyeballing) is not recommended; manual counting using printed images is advocated.
Reproduced with permission from: WHO Classification of Tumours of Endocrine Organs, 4th ed, Lloyd RV, Osamura RY, Klöppel G, Rosai J (Eds), IARC Press, Lyon 2017. p.211. Copyright © 2017 International Agency for Research on Cancer.
Graphic 115945 Version 3.0